Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

Teva Pharma logo

Teva takes controlling stake in genomics specialist

World’s largest generics firm takes deeper steps into patented medicines development

Shire Basingstoke

Shire buys into eyecare specialist

Will complement its investigational dry eye drug lifitegrast

- PMLiVE

Pfizer links with Synthon on generic Copaxone

US giant looking to grab a share of the copycat market for the MS drug

- PMLiVE

Ebola vaccine completely effective, say researchers

Merck earns plaudits for ‘game-changing’ vaccine

- PMLiVE

AstraZeneca expands antisense alliance with Isis

Builds on existing deal that sees the firm develop new medicines for a host of diseases

- PMLiVE

Critical thinking

Assessing the Darwinian model of mutation in pharmaceutical companies

Pharma deals in July 2015

A hot summer month for industry M&A, finds Medius Deal Watch

Merck & Co expands board and adds new directors

Appoints Dr Paul Rothman and Pamela Craig

Roche's Perjeta pertuzumab

European approval for Roche’s next-gen breast cancer drug

Perjeta now available in EU for use before surgery in early stage aggressive breast cancer

- PMLiVE

Humira gains EU licence first for Hidradenitis Suppurativa

Thirteenth licence for the drug in Europe

ABPI Scotland appoints Sandra Auld as director

Takes over from Andrew-Powrie Smith who left to join EPFIA this year

Bristol-Myers Squibb (BMS) building

BMS signs Opdivo combination pact with Kyowa Hakko Kirin 

Rounds off a week of deals in the immunotherapy space for big pharma

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links